Back
Skechers USA Vs. Summit Therapeutics Industry Stock Comparison
Buy
61
SKX
Skechers USA
Last Price:
67.94
Seasonality Move:
-2.77%
Buy
85
SMMT
Summit Therapeutics
Last Price:
26.20
Seasonality Move:
26.72%
Buy
61
Skechers USA (SKX)
is a Buy
Is Skechers USA a Buy, Sell or Hold?
- The current Skechers USA [SKX] share price is $67.86. The Score for SKX is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
- SKX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
85
Summit Therapeutics (SMMT)
is a Buy
Is Summit Therapeutics a Buy, Sell or Hold?
- The current Summit Therapeutics [SMMT] share price is $29.48. The Score for SMMT is 85, which is 70% above its historic median score of 50, and infers lower risk than normal.
- SMMT is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
SKX Stock Price Chart
What is Skechers USA's stock price today?
-
The Skechers USA share price today is $67.86
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SKX is experiencing slight buying pressure.
SMMT Stock Price Chart
What is Summit Therapeutics's stock price today?
-
The Summit Therapeutics share price today is $29.48
The current trend is moderately bullish and SMMT is experiencing selling pressure, which indicates risk of future bearish movement.
SKX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.33 | Buy |
| Relative Strength Index (14 RSI): | 56.26 | Buy |
| Chaikin Money Flow: | 818222 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (64.58 - 68.76) | Buy |
| Bollinger Bands (100): | (63.79 - 70.81) | Buy |
SMMT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.35 | Buy |
| Relative Strength Index (14 RSI): | 80.76 | Buy |
| Chaikin Money Flow: | -10383890 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.54 - 21.66) | Buy |
| Bollinger Bands (100): | (4.24 - 14.54) | Buy |
SKX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 66.43 | Buy |
| 20-day SMA: | 67.44 | Buy |
| 50-day SMA: | 65.48 | Buy |
| 200-day SMA: | 63.92 | Buy |
| 8-day EMA: | 66.86 | Buy |
| 20-day EMA: | 66.64 | Buy |
| 50-day EMA: | 66.33 | Buy |
| 200-day EMA: | 63 | Buy |
SMMT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 22.3 | Buy |
| 20-day SMA: | 16.66 | Buy |
| 50-day SMA: | 12.66 | Buy |
| 200-day SMA: | 6.49 | Buy |
| 8-day EMA: | 23.98 | Buy |
| 20-day EMA: | 18.55 | Buy |
| 50-day EMA: | 13.95 | Buy |
| 200-day EMA: | 7.85 | Buy |
Skechers USA Earnings Growth & SKX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.37 per share, an increase next quarter of $0.18 per share, an increase this year of $0.71 per share, and an increase next year of $0.83 per share.
Summit Therapeutics Earnings Growth & SMMT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.01 per share, an increase this year of $0.32 per share, and a decrease next year of $0.03 per share.
Skechers USA Technical Analysis
| Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Summit Therapeutics Technical Analysis
| Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||